RCM (RCMT) 10-Q 7 Nov 19 2019 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 28, 2019	Nov. 07, 2019
Document Information [Line Items]
Entity Registrant Name	RCM TECHNOLOGIES INC
Entity Central Index Key	0000700841
Trading Symbol	rcmt
Current Fiscal Year End Date	--12-28
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		12,955,847
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Sep. 28, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false
Title of 12(b) Security	Common Stock

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Current assets:
Cash and cash equivalents	$ 393	$ 482
Accounts receivable, net	57,470	52,335
Transit accounts receivable	3,665	2,569
Prepaid expenses and other current assets	3,400	3,425
Total current assets	64,928	58,811
Property and equipment, net	2,841	3,485
Other assets:
Deposits	210	214
Goodwill	16,354	17,532
Operating right of use asset	6,290
Intangible assets, net	496	743
Deferred tax assets, net, domestic	621	725
Total other assets	23,971	19,214
Total assets	91,740	81,510
Current liabilities:
Accounts payable and accrued expenses	6,349	9,969
Transit accounts payable	4,527	2,506
Accrued payroll and related costs	7,057	9,028
Finance lease payable	287
Income taxes payable	538	97
Operating right of use liability	2,275
Liability for contingent consideration from acquisitions	388	1,588
Total current liabilities	21,421	23,188
Deferred tax liability, foreign	402	398
Finance lease payable	194
Liability for contingent consideration from acquisitions	2,673	3,185
Operating right of use liability	4,264
Borrowings under line of credit	31,735	27,540
Total liabilities	60,689	54,311
Stockholders’ equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.05 par value; 40,000,000 shares authorized; 15,779,019 shares issued and 12,955,847 shares outstanding at September 28, 2019 and 15,578,345 shares issued and 12,755,173 shares outstanding at December 29, 2018	788	778
Additional paid-in capital	108,121	107,326
Accumulated other comprehensive loss	(2,757)	(2,755)
Accumulated deficit	(60,114)	(63,163)
Treasury stock (2,823,172 shares at September 28, 2019 and December 29, 2018) at cost	(14,987)	(14,987)
Stockholders’ equity	31,051	27,199
Total liabilities and stockholders’ equity	$ 91,740	$ 81,510

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 28, 2019	Dec. 29, 2018
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	15,779,019	15,578,345
Common stock, outstanding (in shares)	12,955,847	12,755,173
Treasury stock, shares (in shares)	2,823,172	2,823,172

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Revenues	$ 40,250	$ 42,559	$ 142,550	$ 145,081
Cost of services	29,635	31,571	106,615	108,803
Gross profit	10,615	10,988	35,935	36,278
Operating costs and expenses
Selling, general and administrative	9,498	9,412	30,165	29,909
Depreciation and amortization of property and equipment	304	337	944	1,116
Amortization of acquired intangible assets	82	7	247	40
Severance, professional fees and other charges				1,371
Operating costs and expenses	9,884	9,756	31,356	32,436
Operating income	731	1,232	4,579	3,842
Other (expense) income
Interest expense and other, net	(390)	(305)	(1,276)	(971)
Imputed interest on contingent consideration	56		(40)
Gain (loss) on foreign currency transactions	8	10	41	(19)
Other expense, net	(326)	(295)	(1,275)	(990)
Income before income taxes	405	937	3,304	2,852
Income tax expense	70	253	255	736
Net income	$ 335	$ 684	$ 3,049	$ 2,116
Basic and diluted net earnings per share (in dollars per share)	$ 0.03	$ 0.06	$ 0.24	$ 0.17

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Net income	$ 3,049	$ 2,116
Other comprehensive loss	(2)	(177)
Comprehensive income	$ 3,047	$ 1,939

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 30, 2017	15,017,522				2,823,172
Balance at Dec. 30, 2017	$ 751	$ 104,540	$ (2,395)	$ (65,878)	$ (14,987)	$ 22,031
Issuance of stock under employee stock purchase plan (in shares)	45,408
Issuance of stock under employee stock purchase plan	$ 2	192				194
Translation adjustment			(70)			(70)
Share-based compensation expense		112				112
Net income				1,051		1,051
Balance (in shares) at Mar. 31, 2018	15,062,930				2,823,172
Balance at Mar. 31, 2018	$ 753	104,844	(2,465)	(64,827)	$ (14,987)	23,318
Balance (in shares) at Dec. 30, 2017	15,017,522				2,823,172
Balance at Dec. 30, 2017	$ 751	104,540	(2,395)	(65,878)	$ (14,987)	22,031
Translation adjustment						(177)
Net income						2,116
Balance (in shares) at Sep. 29, 2018	15,108,399				2,823,172
Balance at Sep. 29, 2018	$ 755	105,243	(2,572)	(63,762)	$ (14,987)	24,677
Balance (in shares) at Mar. 31, 2018	15,062,930				2,823,172
Balance at Mar. 31, 2018	$ 753	104,844	(2,465)	(64,827)	$ (14,987)	23,318
Issuance of stock under employee stock purchase plan (in shares)
Issuance of stock under employee stock purchase plan
Translation adjustment			(71)			(71)
Share-based compensation expense		89				89
Net income				381		381
Balance (in shares) at Jun. 30, 2018	15,062,930				2,823,172
Balance at Jun. 30, 2018	$ 753	104,933	(2,536)	(64,446)	$ (14,987)	23,717
Issuance of stock under employee stock purchase plan (in shares)	45,469
Issuance of stock under employee stock purchase plan	$ 2	189				191
Translation adjustment			(36)			(36)
Share-based compensation expense		121				121
Net income				684		684
Balance (in shares) at Sep. 29, 2018	15,108,399				2,823,172
Balance at Sep. 29, 2018	$ 755	105,243	(2,572)	(63,762)	$ (14,987)	24,677
Balance (in shares) at Dec. 29, 2018	15,578,345				2,823,172
Balance at Dec. 29, 2018	$ 778	107,326	(2,755)	(63,163)	$ (14,987)	27,199
Issuance of stock under employee stock purchase plan (in shares)	59,451
Issuance of stock under employee stock purchase plan	$ 3	162				165
Translation adjustment			11			11
Share-based compensation expense		241				241
Issuance of stock upon vesting of restricted stock units (in shares)	57,148
Issuance of stock upon vesting of restricted stock units	$ 3	(3)
Net income				1,463		1,463
Balance (in shares) at Mar. 30, 2019	15,694,944				2,823,172
Balance at Mar. 30, 2019	$ 784	107,726	(2,744)	(61,700)	$ (14,987)	29,079
Balance (in shares) at Dec. 29, 2018	15,578,345				2,823,172
Balance at Dec. 29, 2018	$ 778	107,326	(2,755)	(63,163)	$ (14,987)	27,199
Translation adjustment						(2)
Net income						3,049
Balance (in shares) at Sep. 28, 2019	15,779,019				2,823,172
Balance at Sep. 28, 2019	$ 788	108,121	(2,757)	(60,114)	$ (14,987)	31,051
Balance (in shares) at Mar. 30, 2019	15,694,944				2,823,172
Balance at Mar. 30, 2019	$ 784	107,726	(2,744)	(61,700)	$ (14,987)	29,079
Issuance of stock under employee stock purchase plan (in shares)
Issuance of stock under employee stock purchase plan
Translation adjustment			12			12
Share-based compensation expense		207				207
Issuance of stock upon vesting of restricted stock units (in shares)	25,000
Issuance of stock upon vesting of restricted stock units	$ 1	(1)
Net income				1,251		1,251
Balance (in shares) at Jun. 29, 2019	15,719,944				2,823,172
Balance at Jun. 29, 2019	$ 785	107,932	(2,732)	(60,449)	$ (14,987)	30,549
Issuance of stock under employee stock purchase plan (in shares)	59,075
Issuance of stock under employee stock purchase plan	$ 3	153				156
Translation adjustment			(25)			(25)
Share-based compensation expense		24				24
Net income				335		335
Dividends forfeited		12				12
Balance (in shares) at Sep. 28, 2019	15,779,019				2,823,172
Balance at Sep. 28, 2019	$ 788	$ 108,121	$ (2,757)	$ (60,114)	$ (14,987)	$ 31,051

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Cash flows from operating activities:
Net income	$ 3,049	$ 2,116
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	1,191	1,156
Imputed interest on contingent consideration	40
Share-based compensation expense	472	322
Provision for losses on accounts receivable	125	945
Deferred income tax expense	108	104
Changes in assets and liabilities:
Accounts receivable	(5,184)	(1,664)
Prepaid expenses and other current assets	483	(593)
Net of transit accounts receivable and payable	923	(1,560)
Accounts payable and accrued expenses	(3,366)	(219)
Accrued payroll and related costs	(1,986)	905
Right of use assets and liabilities	245
Income taxes payable	30	552
Total adjustments	(6,919)	(52)
Net cash (used in) operating activities	(3,870)	2,064
Cash flows from investing activities:
Property and equipment acquired	(301)	(1,414)
Increase (decrease) in deposits	5	(9)
Net cash used in investing activities	(296)	(1,423)
Cash flows from financing activities:
Borrowings under line of credit	72,201	64,987
Repayments under line of credit	(68,006)	(67,807)
Issuance of stock for employee stock purchase plan	321	385
Changes in finance lease obligations	218
Contingent consideration paid	(574)	(300)
Net cash provided by (used in) financing activities	4,160	(2,735)
Effect of exchange rate changes on cash and cash equivalents	(83)	(47)
Decrease in cash and cash equivalents	(89)	(2,141)
Cash and cash equivalents at beginning of period	482	2,851
Cash and cash equivalents at end of period	393	710
Supplemental cash flow information:
Interest	1,266	832
Income taxes	116	338
Non-cash financing activities:
Vesting of restricted stock units	300
Dividends forfeited on unvested restricted share units	$ (12)

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Basis of Presentation The accompanying consolidated interim financial statements of RCM Technologies, Inc. and subsidiaries (“RCM” or the “Company”) are unaudited. The year-end consolidated balance sheet was derived from audited statements but does not 10 December 29, 2018 10 The consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods. Results for the thirteen thirty-nine September 28, 2019 not may Fiscal Year The Company follows a 52/53 December 31. December 29, 2018 52 third 2019 2018 Period Ended Weeks in Quarter Weeks in Year to Date September 28, 2019 Thirteen Thirty-Nine September 29, 2018 Thirteen Thirty-Nine

Note 2 - Use of Estimates and U

Note 2 - Use of Estimates and Uncertainties	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2. Use of Estimates and Uncertainties The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts. These estimates can be significant to the operating results and financial position of the Company. The Company has risk participation arrangements with respect to workers compensation and health care insurance. The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs. The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company’s services, adverse litigation and claims and the hiring, training and retention of key employees. Fair Value of Financial Instruments The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit’s variable interest rate. The Company does not

Note 3 - Revenue Recognition

Note 3 - Revenue Recognition	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	3. Revenue Recognition The Company records revenue under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers We evaluate our revenue contracts with customers based on the five 606: 1 2 3 4 5 The Company derives its revenue from several sources. The Company’s Engineering Services and Information Technology Services segments perform consulting and project solution services. All of the Company’s segments perform staff augmentation services and derive revenue from permanent placement fees. The majority of the Company’s revenue is invoiced on a time and materials basis. The following table presents our revenue disaggregated by revenue source for the thirteen thirty-nine September 28, 2019 September 29, 2018: Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Engineering: Time and Material $ 13,938 $ 17,601 $ 41,309 $ 56,639 Fixed Fee 1,202 1,823 11,469 5,773 Permanent Placement Services - - - - Total Engineering $ 15,140 $ 19,424 $ 52,778 $ 62,412 Specialty Health Care: Time and Material $ 16,272 $ 14,760 $ 63,318 $ 59,457 Permanent Placement Services 493 347 987 1,142 Total Specialty Health Care $ 16,765 $ 15,107 $ 64,305 $ 60,599 Information Technology: Time and Material $ 8,134 $ 7,925 $ 25,084 $ 21,875 Permanent Placement Services 211 103 383 195 Total Information Technology $ 8,345 $ 8,028 $ 25,467 $ 22,070 $ 40,250 $ 42,559 $ 142,550 $ 145,081 Time and Material The Company’s IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company’s time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. Fixed fee From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables. The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company’s fixed fee purchase orders are typically performed over six nine not not Permanent Placement Services The Company earns permanent placement fees from providing permanent placement services. These fees are typically based on a percentage of the compensation paid to the person placed with the Company’s client. Deferred revenue was $288 $150 September 28, 2019 December 29, 2018, may one thirty-nine September 28, 2019, $150

Note 4 - Accounts Receivable, T

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	4. Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable The Company’s accounts receivable are comprised as follows: September 28, 2019 December 29, 2018 Billed $ 25,889 $ 32,323 Accrued and unbilled 17,191 10,383 Work-in-progress 3,758 2,252 Accounts receivable subject to arbitration 12,177 8,820 Allowance for sales discounts and doubtful accounts (1,545 ) (1,443 ) Accounts receivable, net $ 57,470 $ 52,335 Unbilled receivables primarily represent revenue earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-progress primarily represents revenue earned under contracts which the Company contractually invoices at future dates. From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services. Pursuant to these agreements, the Company a) may no not not not $3.7 $4.5 $0.8 September 28, 2019. $2.6 $2.5 $0.1 December 29, 2018. The Company has a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 2018. not September 28, 2019 December 29, 2018, $12.2 $8.9 September 28, 2019, $10.3 not no 2019 no not one not

Note 5 - Property and Equipment

Note 5 - Property and Equipment	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. Property and Equipment Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are 20% Property and equipment are comprised of the following: September 28, 2019 December 29, 2018 Computers and systems $ 6,043 $ 7,200 Equipment and furniture 523 600 Leasehold improvements 475 743 7,041 8,543 Less: accumulated depreciation and amortization 4,200 5,058 Property and equipment, net $ 2,841 $ 3,485 The Company periodically writes off fully depreciated and amortized assets. The Company wrote off fully depreciated and amortized assets of $1,803 $994 thirty-nine September 28, 2019 September 29, 2018, thirteen September 28, 2019 September 29, 2018, $183 $283,

Note 6 - Acquisitions

Note 6 - Acquisitions	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Business Combination Disclosure [Text Block]	6. Acquisitions The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration. The Company gives no no Future Contingent Payments As of September 28, 2019, two may 1 October 1, 2017, 2 September 30, 2018, September 28, 2019 Fiscal Year Ending Total December 28, 2019 (after September 28, 2019) $ - January 2, 2021 388 January 1, 2022 1,754 December 31, 2022 919 Estimated future contingent consideration payments $ 3,061 Estimates of future contingent payments are subject to significant judgment and actual payments may September 28, 2019 $6.3 September 28, 2019. thirty-nine September 28, 2019, 3 For acquisitions that involve contingent consideration, the Company records a liability equal to the fair value of the estimated contingent consideration obligation as of the acquisition date. The Company determines the acquisition date fair value of the contingent consideration based on the likelihood of paying the additional consideration. The fair value is estimated using projected future operating results and the corresponding future earn-out payments that can be earned upon the achievement of specified operating objectives and financial results by acquired companies using Level 3 may one The Company paid contingent consideration of $0.6 $0.3 thirty-nine September 28, 2019 September 29, 2018, TKE Effective September 30, 2018, $1.2 Cash $ 1,066 Common stock of the Company 1,878 Contingent consideration, at fair value 1,757 Total consideration $ 4,701 The shareholders of TKE are eligible to receive post-closing contingent consideration upon the business exceeding certain base levels of operating income, potentially earned over three three Fixed assets $ 12 Restricted covenants 50 Customer relationships 720 Goodwill 4,669 Less: net liabilities assumed (750 ) Total consideration $ 4,701 The results of operations of TKE have been included in the consolidated statement of operations as of the effective date of acquisition. The following revenue and operating loss of TKE are included in the Company’s consolidated results of operations: Thirteen Week Thirty-Nine Week Period Ended September 28, 2019 Period Ended September 28, 2019 Revenue $ 398 $ 3,761 Operating loss $ (236 ) $ (63 ) The following table represents the pro forma revenue and earnings for the thirteen thirty-nine September 29, 2018: Thirteen Week Period Ended September 29, 2018 Thirty-Nine Week Period Ended September 29, 2018 Historical Pro Forma Combined (Unaudited) Historical Pro Forma Combined (Unaudited) Revenue $ 42,559 $ 44,352 $ 145,081 $ 150,161 Operating income $ 1,232 $ 1,538 $ 3,842 $ 4,760 Diluted net income per share $ 0.06 $ 0.07 $ 0.17 $ 0.22 The combined pro forma revenue and operating income for the quarter ended September 29, 2018 January 1, 2018. not not

Note 7 - Goodwill

Note 7 - Goodwill	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Goodwill Disclosure [Text Block]	7. Goodwill Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations. The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill may no thirty-nine September 28, 2019 September 29, 2018. The changes in the carrying amount of goodwill for the thirty-nine September 28, 2019 Engineering Specialty Health Care Information Technology Total Balance as of December 29, 2018 $ 13,096 $ 2,398 $ 2,038 $ 17,532 Adjustment to final TKE purchase price (1,178 ) - - (1,178 ) Balance as of September 28, 2019 $ 11,918 $ 2,398 $ ,2038 $ 16,354

Note 8 - Intangible Assets

Note 8 - Intangible Assets	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	8. Intangible Assets The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not not no All of the Company’s intangible assets are associated with the Engineering segment. Intangible assets other than goodwill are amortized over their useful lives. Intangible assets are carried at cost, less accumulated amortization. Thirty-Nine Week Periods Ended September 28, 2019 December 29, 2018 Restricted covenants $ 32 $ 51 Customer relationships 464 692 Total intangible assets $ 496 $ 743 Amortization expense of intangible assets for the thirty-nine September 28, 2019 September 29, 2018 $247 $40, thirteen September 28, 2019 September 29, 2018, $82 $7,

Note 9 - Line of Credit

Note 9 - Line of Credit	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Debt Disclosure [Text Block]	9. Line of Credit The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on October 18, 2019. $45.0 no August 8, 2023. Borrowings under the Revolving Credit Facility bear interest at one two 30 not thirty-nine September 28, 2019 September 29, 2018 4.6% 3.8%, All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries. The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts on the Company’s ability to borrow in order to pay dividends. As of September 28, 2019, Borrowings under the line of credit as of September 28, 2019 December 29, 2018 $31.7 $27.5 September 28, 2019 December 29, 2018 $1.6 September 28, 2019, $11.7

Note 10 - Per Share Data

Note 10 - Per Share Data	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Earnings Per Share [Text Block]	1 0 . Per Share Data The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share. The number of common shares used to calculate basic and diluted earnings per share for the thirteen thirty-nine September 28, 2019 September 29, 2018 Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Basic weighted average shares outstanding 12,955,198 12,284,727 12,897,303 12,254,415 Dilutive effect of outstanding restricted share units 63,416 32,723 53,628 24,165 Weighted average dilutive shares outstanding 13,018,614 12,317,450 12,950,931 12,278,580 For all periods presented, there were no not no Unissued shares of common stock were reserved for the following purposes: September 28, 2019 December 29, 2018 Time-based restricted stock units outstanding 120,372 147,372 Performance-based restricted stock units outstanding 320,000 200,000 Future grants of options or shares 267,551 442,699 Shares reserved for employee stock purchase plan 267,877 386,403 Total 975,800 1,176,474

Note 11 - Share-based Compensat

Note 11 - Share-based Compensation	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	11. Share-Based Compensation At September 28, 2019, two one three 10 may The Company recognized share-based compensation expense of $472 $322 thirty-nine September 28, 2019, September 29, 2018, thirteen September 28, 2019 September 29, 2018, $24 $121, September 28, 2019, As of September 28, 2019, $0.1 two not Incentive S hare-Based Plans 2014 2014 The 2014 December 2014, 625,000 2016, 2014 500,000 1,125,000 December 1, 2026. As of September 28, 2019, 2014 120,372 320,000 267,551 Employee Stock Purchase Plan The Company implemented the 2001 January 1, 2001. 85% 10% In fiscal 2015, 300,000 1,100,000 December 31, 2025. 2018, 300,000 1,400,000 The Company has two first two two first July 1, 2019) 59,075. September 28, 2019, 267,877 Time-Based Restricted Stock Units From time-to-time the Company issues time-based restricted stock units. These time-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. As of September 28, 2019, $40 not To date, the Company has issued time-based restricted stock units only under its 2007 2014 2007 no 2014 thirty-nine September 28, 2019: Number of Time-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 29, 2018 147,372 $ 4.46 Granted 20,000 $ 3.73 Vested (35,000 ) $ 4.41 Forfeited or expired (12,000 ) $ 5.84 Outstanding non-vested at September 28, 2019 120,372 $ 4.22 Based on the closing price of the Company’s common stock of $3.04 September 27, 2019 ( September 28, 2019), September 28, 2019 $366. September 28, 2019, $138 Performance Based Restricted Stock Units From time-to-time the Company issues performance-based restricted stock units to its executives. Performance-based restricted stock units are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock units that actually vest, if any. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. As of September 28, 2019, no not To date, the Company has issued performance-based restricted stock units only under the 2014 thirty-nine September 28, 2019: Number of Performance- Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 29, 2018 200,000 $ 5.06 Granted 167,148 $ 4.35 Vested (47,148 ) $ 3.69 Forfeited or expired - $ - Outstanding non-vested at September 28, 2019 320,000 $ 4.82 As of September 28, 2019, 320,000 September 28, 2019, $1.5

Note 12 - Treasury Stock Transa

Note 12 - Treasury Stock Transactions	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Treasury Stock [Text Block]	12. Treasury Stock Transactions For both the thirty-nine September 28, 2019 September 29, 2018, not not

Note 13 - New Accounting Standa

Note 13 - New Accounting Standards and Updates From the Securities Exchange Commission ("SEC")	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	13. New Accounting Standards and Updates from the Securities Exchange Commission (“SEC”) In June 2016, 2016 13, Financial Instruments - Credit Losses (Topic 326 December 15, 2019, not 2016 13

Note 14 - Segment Information

Note 14 - Segment Information	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	1 4 . Segment Information The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 10 December 29, 2018). Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system: Thirteen Week Period Ended September 28, 2019 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 15,140 $ 16,765 $ 8,345 $ - $ 40,250 Cost of services 10,984 12,795 5,856 - 29,635 Gross profit 4,156 3,970 2,489 - 10,615 Selling, general and administrative 2,996 4,205 2,297 - 9,498 Depreciation and amortization 293 74 19 - 386 Operating income (loss) $ 867 $ (309 ) $ 173 $ - $ 731 Total assets as of September 28, 2019 $ 53,639 $ 25,822 $ 7,773 $ 4,506 $ 91,740 Capital expenditures $ (11 ) $ 2 $ 19 $ 53 $ 63 Thirteen Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 19,424 $ 15,106 $ 8,029 $ - $ 42,559 Cost of services 14,049 11,665 5,857 - 31,571 Gross profit 5,375 3,441 2,172 - 10,988 Selling, general and administrative 3,780 3,648 1,984 - 9,412 Depreciation and amortization 236 85 23 - 344 Operating income (loss) $ 1,359 $ (292 ) $ 165 $ - $ 1,232 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 465 $ 151 $ 90 $ 110 $ 816 Thirty-Nine Week Period Ended September 28, 2019 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 52,778 $ 64,305 $ 25,467 $ - $ 142,550 Cost of services 38,666 49,395 18,554 - 106,615 Gross profit 14,112 14,910 6,913 - 35,935 Selling, general and administrative 10,486 12,990 6,689 - 30,165 Depreciation and amortization 879 250 62 - 1,191 Operating income $ 2,747 $ 1,670 $ 162 $ - $ 4,579 Total assets as of September 28, 2019 $ 53,639 $ 25,822 $ 7,773 $ 4,506 $ 91,740 Capital expenditures $ 76 $ 107 $ 36 $ 82 $ 301 Thirty-Nine Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 62,412 $ 60,599 $ 22,070 $ - $ 145,081 Cost of services 45,706 46,822 16,275 - 108,803 Gross profit 16,706 13,777 5,795 - 36,278 Selling, general and administrative 12,006 12,255 5,648 - 29,909 Depreciation and amortization 785 294 77 - 1,156 Severance, professional fees and other charges - - - 1,371 1,371 Operating income (loss) $ 3,915 $ 1,228 $ 70 $ (1,371 ) $ 3,842 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 856 $ 207 $ 108 $ 243 $ 1,414 The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the thirteen thirty-nine September 28, 2019 September 29, 2018 Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Revenue U. S. $ 34,810 $ 34,729 $ 124,356 $ 118,364 Canada 3,682 6,308 12,770 21,942 Puerto Rico 1,215 1,113 3,627 3,142 Serbia 543 409 1,797 1,633 $ 40,250 $ 42,559 $ 142,550 $ 145,081 Total assets by geographic area as of the reported periods are as follows: September 28, 2019 December 29, 2018 Total assets U. S. $ 72,814 $ 61,417 Canada 12,316 14,230 Puerto Rico 1,997 1,954 Serbia 4,616 3,909 $ 91,740 $ 81,510

Note 15 - Income Taxes

Note 15 - Income Taxes	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Income Tax Disclosure [Text Block]	15. Income Taxes The Company recognized $0.3 thirty-nine September 28, 2019, $0.7 $0.6 first 2019 25.9% 25.8% Not $0.6 2019 September 28, 2019 28.3%, 26.5% 15.0% 28.1%, 26.5% 15.2% 25.8% thirty-nine September 29, 2018. thirty-nine September 28, 2019

Note 16 - Contingencies

Note 16 - Contingencies	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Contingencies Disclosure [Text Block]	16. Contingencies From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries. The Company may not may $10.3 September 28, 2019. September 28, 2019, not The Company has a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 2018. not September 28, 2019 December 29, 2018, $12.2 $8.9 September 28, 2019, $10.3 not no 2019 no not one not The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which may not

Note 17 - Leases

Note 17 - Leases	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	17. Leases In February 2016, No. 2016 02, Leases (Topic 842 12 842, 842”. On December 30, 2018, 842 December 30, 2018 842, not 840, Leases not 842, not not not December 30, 2018. As a result of the cumulative impact of adopting ASC 842, $3.9 $4.1 December 30, 2018, The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not . The components of lease expense were as follows: Thirteen Week Period Ended September 28, 2019 Thirty-Nine Week Period Ended September 28, 2019 Operating lease cost $ 654 $ 1,643 Amortization of ROU assets $ 72 $ 218 Interest on lease liabilities 1 4 Total finance lease cost $ 73 $ 222 Supplemental Cash Flow information related to leases was as follows: Thirteen Week Period Ended September 28, 2019 Thirty-Nine Week Period Ended September 28, 2019 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 665 $ 1,605 Operating cash flows from finance leases 1 4 Financing cash flows from finance leases 72 216 Right of use assets obtained in exchange for lease obligations Operating leases 774 7,756 Finance leases - - Supplemental Balance Sheet information as of September 28, 2019 Operating leases Operating lease right of use assets $ 6,290 Other current liabilities $ (2,275 ) Operating lease liabilities (4,264 ) Total operating lease liabilities $ (6,539 ) Finance leases Property and equipment - (ROU assets) $ 867 Accumulated depreciation (387 ) Property and equipment, net $ 480 Other current liabilities $ (287 ) Other long term liabilities (194 ) Total finance lease liabilities $ (481 ) Weighted average remaining lease term Operating leases (years) 2.24 Finance leases (years) 1.7 Weighted average discount rate Operating leases 4.09 % Finance leases 1.23 % Maturities of lease liabilities are as follows: Fiscal Year Ending Operating Leases Finance Leases 2019 $ 673 $ 73 2020 2,289 284 2021 1,715 130 2022 1,266 - 2023 877 - Thereafter 186 - Total lease payments 7,006 487 Less: imputed interest (467 ) (6 ) Total $ 6,539 $ 481

Note 18 - Severance, Profession

Note 18 - Severance, Professional Fees, and Other Charges	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Severance, Professional Fees and Other Charges Disclosure [Text Block]	1 8 . Severance, Professional Fees and Other Charges The Company recorded $1.4 thirty-nine September 29, 2018. $0.9 $0.5 not

Note 19 - Subsequent Event

Note 19 - Subsequent Event	9 Months Ended
	Sep. 28, 2019
Notes to Financial Statements
Subsequent Events [Text Block]	19. Subsequent Event Amendment to Loan Agreement The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on October 18, 2019. 9.

Note 3 - Revenue Recognition (T

Note 3 - Revenue Recognition (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Disaggregation of Revenue [Table Text Block]	Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Engineering: Time and Material $ 13,938 $ 17,601 $ 41,309 $ 56,639 Fixed Fee 1,202 1,823 11,469 5,773 Permanent Placement Services - - - - Total Engineering $ 15,140 $ 19,424 $ 52,778 $ 62,412 Specialty Health Care: Time and Material $ 16,272 $ 14,760 $ 63,318 $ 59,457 Permanent Placement Services 493 347 987 1,142 Total Specialty Health Care $ 16,765 $ 15,107 $ 64,305 $ 60,599 Information Technology: Time and Material $ 8,134 $ 7,925 $ 25,084 $ 21,875 Permanent Placement Services 211 103 383 195 Total Information Technology $ 8,345 $ 8,028 $ 25,467 $ 22,070 $ 40,250 $ 42,559 $ 142,550 $ 145,081

Note 4 - Accounts Receivable,_2

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 28, 2019 December 29, 2018 Billed $ 25,889 $ 32,323 Accrued and unbilled 17,191 10,383 Work-in-progress 3,758 2,252 Accounts receivable subject to arbitration 12,177 8,820 Allowance for sales discounts and doubtful accounts (1,545 ) (1,443 ) Accounts receivable, net $ 57,470 $ 52,335

Note 5 - Property and Equipme_2

Note 5 - Property and Equipment (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 28, 2019 December 29, 2018 Computers and systems $ 6,043 $ 7,200 Equipment and furniture 523 600 Leasehold improvements 475 743 7,041 8,543 Less: accumulated depreciation and amortization 4,200 5,058 Property and equipment, net $ 2,841 $ 3,485

Note 6 - Acquisitions (Tables)

Note 6 - Acquisitions (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]	Fiscal Year Ending Total December 28, 2019 (after September 28, 2019) $ - January 2, 2021 388 January 1, 2022 1,754 December 31, 2022 919 Estimated future contingent consideration payments $ 3,061
Schedule of Business Combination Consideration Transferred and Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Cash $ 1,066 Common stock of the Company 1,878 Contingent consideration, at fair value 1,757 Total consideration $ 4,701
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Fixed assets $ 12 Restricted covenants 50 Customer relationships 720 Goodwill 4,669 Less: net liabilities assumed (750 ) Total consideration $ 4,701
Business Acquisition, Amounts Included in Statement of Operations [Table Text Block]	Thirteen Week Thirty-Nine Week Period Ended September 28, 2019 Period Ended September 28, 2019 Revenue $ 398 $ 3,761 Operating loss $ (236 ) $ (63 )
Business Acquisition, Pro Forma Information [Table Text Block]	Thirteen Week Period Ended September 29, 2018 Thirty-Nine Week Period Ended September 29, 2018 Historical Pro Forma Combined (Unaudited) Historical Pro Forma Combined (Unaudited) Revenue $ 42,559 $ 44,352 $ 145,081 $ 150,161 Operating income $ 1,232 $ 1,538 $ 3,842 $ 4,760 Diluted net income per share $ 0.06 $ 0.07 $ 0.17 $ 0.22

Note 7 - Goodwill (Tables)

Note 7 - Goodwill (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Goodwill [Table Text Block]	Engineering Specialty Health Care Information Technology Total Balance as of December 29, 2018 $ 13,096 $ 2,398 $ 2,038 $ 17,532 Adjustment to final TKE purchase price (1,178 ) - - (1,178 ) Balance as of September 28, 2019 $ 11,918 $ 2,398 $ ,2038 $ 16,354

Note 8 - Intangible Assets (Tab

Note 8 - Intangible Assets (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Thirty-Nine Week Periods Ended September 28, 2019 December 29, 2018 Restricted covenants $ 32 $ 51 Customer relationships 464 692 Total intangible assets $ 496 $ 743

Note 10 - Per Share Data (Table

Note 10 - Per Share Data (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Weighted Average Number of Shares [Table Text Block]	Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Basic weighted average shares outstanding 12,955,198 12,284,727 12,897,303 12,254,415 Dilutive effect of outstanding restricted share units 63,416 32,723 53,628 24,165 Weighted average dilutive shares outstanding 13,018,614 12,317,450 12,950,931 12,278,580
Unissued Shares of Common Stock [Table Text Block]	September 28, 2019 December 29, 2018 Time-based restricted stock units outstanding 120,372 147,372 Performance-based restricted stock units outstanding 320,000 200,000 Future grants of options or shares 267,551 442,699 Shares reserved for employee stock purchase plan 267,877 386,403 Total 975,800 1,176,474

Note 11 - Share-based Compens_2

Note 11 - Share-based Compensation (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Number of Time-Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 29, 2018 147,372 $ 4.46 Granted 20,000 $ 3.73 Vested (35,000 ) $ 4.41 Forfeited or expired (12,000 ) $ 5.84 Outstanding non-vested at September 28, 2019 120,372 $ 4.22 Number of Performance- Based Restricted Stock Units Weighted Average Grant Date Fair Value per Share Outstanding non-vested at December 29, 2018 200,000 $ 5.06 Granted 167,148 $ 4.35 Vested (47,148 ) $ 3.69 Forfeited or expired - $ - Outstanding non-vested at September 28, 2019 320,000 $ 4.82

Note 14 - Segment Information (

Note 14 - Segment Information (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Thirteen Week Period Ended September 28, 2019 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 15,140 $ 16,765 $ 8,345 $ - $ 40,250 Cost of services 10,984 12,795 5,856 - 29,635 Gross profit 4,156 3,970 2,489 - 10,615 Selling, general and administrative 2,996 4,205 2,297 - 9,498 Depreciation and amortization 293 74 19 - 386 Operating income (loss) $ 867 $ (309 ) $ 173 $ - $ 731 Total assets as of September 28, 2019 $ 53,639 $ 25,822 $ 7,773 $ 4,506 $ 91,740 Capital expenditures $ (11 ) $ 2 $ 19 $ 53 $ 63 Thirteen Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 19,424 $ 15,106 $ 8,029 $ - $ 42,559 Cost of services 14,049 11,665 5,857 - 31,571 Gross profit 5,375 3,441 2,172 - 10,988 Selling, general and administrative 3,780 3,648 1,984 - 9,412 Depreciation and amortization 236 85 23 - 344 Operating income (loss) $ 1,359 $ (292 ) $ 165 $ - $ 1,232 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 465 $ 151 $ 90 $ 110 $ 816 Thirty-Nine Week Period Ended September 28, 2019 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 52,778 $ 64,305 $ 25,467 $ - $ 142,550 Cost of services 38,666 49,395 18,554 - 106,615 Gross profit 14,112 14,910 6,913 - 35,935 Selling, general and administrative 10,486 12,990 6,689 - 30,165 Depreciation and amortization 879 250 62 - 1,191 Operating income $ 2,747 $ 1,670 $ 162 $ - $ 4,579 Total assets as of September 28, 2019 $ 53,639 $ 25,822 $ 7,773 $ 4,506 $ 91,740 Capital expenditures $ 76 $ 107 $ 36 $ 82 $ 301 Thirty-Nine Week Period Ended September 29, 2018 Engineering Specialty Health Care Information Technology Corporate Total Revenue $ 62,412 $ 60,599 $ 22,070 $ - $ 145,081 Cost of services 45,706 46,822 16,275 - 108,803 Gross profit 16,706 13,777 5,795 - 36,278 Selling, general and administrative 12,006 12,255 5,648 - 29,909 Depreciation and amortization 785 294 77 - 1,156 Severance, professional fees and other charges - - - 1,371 1,371 Operating income (loss) $ 3,915 $ 1,228 $ 70 $ (1,371 ) $ 3,842 Total assets as of September 29, 2018 $ 40,643 $ 18,874 $ 7,110 $ 6,801 $ 73,428 Capital expenditures $ 856 $ 207 $ 108 $ 243 $ 1,414
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	Thirteen Week Periods Ended Thirty-Nine Week Periods Ended September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018 Revenue U. S. $ 34,810 $ 34,729 $ 124,356 $ 118,364 Canada 3,682 6,308 12,770 21,942 Puerto Rico 1,215 1,113 3,627 3,142 Serbia 543 409 1,797 1,633 $ 40,250 $ 42,559 $ 142,550 $ 145,081
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]	September 28, 2019 December 29, 2018 Total assets U. S. $ 72,814 $ 61,417 Canada 12,316 14,230 Puerto Rico 1,997 1,954 Serbia 4,616 3,909 $ 91,740 $ 81,510

Note 17 - Leases (Tables)

Note 17 - Leases (Tables)	9 Months Ended
	Sep. 28, 2019
Notes Tables
Lease, Cost [Table Text Block]	Thirteen Week Period Ended September 28, 2019 Thirty-Nine Week Period Ended September 28, 2019 Operating lease cost $ 654 $ 1,643 Amortization of ROU assets $ 72 $ 218 Interest on lease liabilities 1 4 Total finance lease cost $ 73 $ 222
Lease, Cash Flow Information [Table Text Block]	Thirteen Week Period Ended September 28, 2019 Thirty-Nine Week Period Ended September 28, 2019 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 665 $ 1,605 Operating cash flows from finance leases 1 4 Financing cash flows from finance leases 72 216 Right of use assets obtained in exchange for lease obligations Operating leases 774 7,756 Finance leases - -
Lease, Balance Sheet Information [Table Text Block]	Operating leases Operating lease right of use assets $ 6,290 Other current liabilities $ (2,275 ) Operating lease liabilities (4,264 ) Total operating lease liabilities $ (6,539 ) Finance leases Property and equipment - (ROU assets) $ 867 Accumulated depreciation (387 ) Property and equipment, net $ 480 Other current liabilities $ (287 ) Other long term liabilities (194 ) Total finance lease liabilities $ (481 ) Weighted average remaining lease term Operating leases (years) 2.24 Finance leases (years) 1.7 Weighted average discount rate Operating leases 4.09 % Finance leases 1.23 %
Lease, Liability, Maturity [Table Text Block]	Fiscal Year Ending Operating Leases Finance Leases 2019 $ 673 $ 73 2020 2,289 284 2021 1,715 130 2022 1,266 - 2023 877 - Thereafter 186 - Total lease payments 7,006 487 Less: imputed interest (467 ) (6 ) Total $ 6,539 $ 481

Note 3 - Revenue Recognition (D

Note 3 - Revenue Recognition (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Dec. 29, 2018
Contract with Customer, Liability, Revenue Recognized	$ 150
Accounts Payable and Accrued Liabilities [Member]
Contract with Customer, Liability, Total	$ 288	$ 150

Note 3 - Revenue Recognition -

Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Revenues	$ 40,250	$ 42,559	$ 142,550	$ 145,081
Engineering Services [Member]
Revenues	15,140	19,424	52,778	62,412
Health Care [Member]
Revenues	16,765	15,107	64,305	60,599
Technology Service [Member]
Revenues	8,345	8,028	25,467	22,070
Time-and-materials Contract [Member] | Engineering Services [Member]
Revenues	13,938	17,601	41,309	56,639
Time-and-materials Contract [Member] | Health Care [Member]
Revenues	16,272	14,760	63,318	59,457
Time-and-materials Contract [Member] | Technology Service [Member]
Revenues	8,134	7,925	25,084	21,875
Fixed-price Contract [Member] | Engineering Services [Member]
Revenues	1,202	1,823	11,469	5,773
Permanent Placement Services [Member] | Engineering Services [Member]
Revenues
Permanent Placement Services [Member] | Health Care [Member]
Revenues	493	347	987	1,142
Permanent Placement Services [Member] | Technology Service [Member]
Revenues	$ 211	$ 103	$ 383	$ 195

Note 4 - Accounts Receivable,_3

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Details Textual) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Accounts Receivable, after Allowance for Credit Loss, Current, Total	$ 57,470	$ 52,335
Loss Contingency, Receivable, Ending Balance	12,200	8,900
Loss Contingency, Estimate of Possible Loss	10,300
Collectibility of Receivables [Member]
Loss Contingency, Estimate of Possible Loss	10,300
Transit Accounts Payable [Member]
Accounts Payable, Current, Total	4,500	2,500
Transit Accounts Receivable [Member]
Accounts Receivable, before Allowance for Credit Loss, Current	3,700	2,600
Accounts Receivable, after Allowance for Credit Loss, Current, Total	$ 800	$ 100

Note 4 - Accounts Receivable,_4

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable - Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Allowance for sales discounts and doubtful accounts	$ (1,545)	$ (1,443)
Accounts receivable, net	57,470	52,335
Billed Revenues [Member]
Accounts receivable, current	25,889	32,323
Unbilled Revenues [Member]
Accounts receivable, current	17,191	10,383
Work In Progress [Member]
Accounts receivable, current	3,758	2,252
Accounts Receivable Subject to Arbitration [Member]
Accounts receivable, current	$ 12,177	$ 8,820

Note 5 - Property and Equipme_3

Note 5 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Annual Depreciation Rate	20.00%		20.00%
Write Off of Fully Depreciated Property and Equipment	$ 183	$ 283	$ 1,803	$ 994

Note 5 - Property and Equipme_4

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Property and equipment	$ 7,041	$ 8,543
Less: accumulated depreciation and amortization	4,200	5,058
Property and equipment, net	2,841	3,485
Computers and Systems [Member]
Property and equipment	6,043	7,200
Equipment and Furniture [Member]
Property and equipment	523	600
Leasehold Improvements [Member]
Property and equipment	$ 475	$ 743

Note 6 - Acquisitions (Details

Note 6 - Acquisitions (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 28, 2019	Sep. 29, 2018
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		$ 6,300
Payment for Contingent Consideration Liability, Financing Activities		574	$ 300
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability		$ 40
TKE [Member]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$ (1,200)

Note 6 - Acquisitions - Maximum

Note 6 - Acquisitions - Maximum Deferred Consideration Payments (Details) $ in Thousands	Sep. 28, 2019USD ($)
December 28, 2019 (after September 28, 2019)
January 2, 2021	388
January 1, 2022	1,754
December 31, 2022	919
Estimated future contingent consideration payments	$ 3,061

Note 6 - Acquisitions - Prelimi

Note 6 - Acquisitions - Preliminary Consideration and Estimated Fair Value Assets Acquired and Liabilities Assumed (Details) - TKE [Member] $ in Thousands	Sep. 30, 2018USD ($)
Cash	$ 1,066
Common stock of the Company	1,878
Contingent consideration, at fair value	1,757
Total consideration	$ 4,701

Note 6 - Acquisitions - Preli_2

Note 6 - Acquisitions - Preliminary Estimated Purchase Price Allocation (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018	Sep. 30, 2018
Goodwill	$ 16,354	$ 17,532
TKE [Member]
Fixed assets			$ 12
Goodwill			4,669
Less: net liabilities assumed			(750)
Total consideration			4,701
TKE [Member] | Restricted Covenants [Member]
Intangible assets, net			50
TKE [Member] | Customer Relationships [Member]
Intangible assets, net			$ 720

Note 6 - Acquisitions - Revenue

Note 6 - Acquisitions - Revenue and Operating Income Included in Consolidated Income (Details) - TKE [Member] - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 28, 2019	Sep. 28, 2019
Revenue	$ 398	$ 3,761
Operating loss	$ (236)	$ (63)

Note 6 - Acquisitions - Proform

Note 6 - Acquisitions - Proforma Revenue and Earnings (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Revenue	$ 40,250	$ 42,559	$ 142,550	$ 145,081
Operating income	$ 731	$ 1,232	$ 4,579	$ 3,842
Diluted net income per share (in dollars per share)		$ 0.06		$ 0.17
TKE [Member]
Revenue		$ 44,352		$ 150,161
Operating income		$ 1,538		$ 4,760
Diluted net income per share (in dollars per share)		$ 0.07		$ 0.22

Note 7 - Goodwill (Details Text

Note 7 - Goodwill (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Goodwill, Impairment Loss	$ 0	$ 0

Note 7 - Goodwill - Changes in

Note 7 - Goodwill - Changes in Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 28, 2019USD ($)
Balance	$ 17,532
Adjustment to final TKE purchase price	(1,178)
Balance	16,354
Engineering [Member]
Balance	13,096
Adjustment to final TKE purchase price	(1,178)
Balance	11,918
Specialty Health Care [Member]
Balance	2,398
Adjustment to final TKE purchase price
Balance	2,398
Information Technology [Member]
Balance	2,038
Adjustment to final TKE purchase price
Balance	$ 2,038

Note 8 - Intangible Assets (Det

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 0	$ 0	$ 0	$ 0
Amortization of Intangible Assets, Total	$ 82	$ 7	$ 247	$ 40

Note 8 - Intangible Assets - In

Note 8 - Intangible Assets - Intangible Assets by Class (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Intangible assets, net	$ 496	$ 743
Restricted Covenants [Member]
Intangible assets, net	32	51
Customer Relationships [Member]
Intangible assets, net	$ 464	$ 692

Note 9 - Line of Credit (Detail

Note 9 - Line of Credit (Details Textual) - USD ($) $ in Thousands	Oct. 18, 2019	Sep. 28, 2019	Dec. 29, 2018	Sep. 29, 2018
Long-term Line of Credit, Noncurrent		$ 31,735	$ 27,540
Citizens Bank of Pennsylvania [Member] | Revolving Credit Facility [Member]
Debt Instrument, Interest Rate, Effective Percentage		4.60%		3.80%
Long-term Line of Credit, Noncurrent		$ 31,700	27,500
Letters of Credit Outstanding, Amount		1,600	$ 1,600
Line of Credit Facility, Remaining Borrowing Capacity		$ 11,700
Citizens Bank of Pennsylvania [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 45,000

Note 10 - Per Share Data (Detai

Note 10 - Per Share Data (Details Textual) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0	0	0

Note 10 - Per Share Data - Weig

Note 10 - Per Share Data - Weighted Average Number of Common Shares (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Basic weighted average shares outstanding (in shares)	12,955,198	12,284,727	12,897,303	12,254,415
Dilutive effect of outstanding restricted share units (in shares)	63,416	32,723	53,628	24,165
Weighted average dilutive shares outstanding (in shares)	13,018,614	12,317,450	12,950,931	12,278,580

Note 10 - Per Share Data - Unis

Note 10 - Per Share Data - Unissued Shares of Common Stock Were Reserved for the Following Purposes (Details) - shares	Sep. 28, 2019	Dec. 29, 2018
Future grants of options or shares (in shares)	267,551	442,699
Shares reserved for employee stock purchase plan (in shares)	267,877	386,403
Total (in shares)	975,800	1,176,474
Time-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)	120,372	147,372
Performance-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)	320,000	200,000

Note 11 - Share-based Compens_3

Note 11 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2018	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018	Dec. 29, 2018	Dec. 31, 2016	Dec. 27, 2015	Sep. 27, 2019	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period				10 years
Share-based Payment Arrangement, Expense		$ 24	$ 121	$ 472	$ 322
Common Stock, Capital Shares Reserved for Future Issuance		975,800		975,800		1,176,474
Share Price									$ 3.04
The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		1,125,000		1,125,000						625,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized							500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		267,551		267,551
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		267,877		267,877
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date				85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate		10.00%		10.00%
Additional Shares of Common Stock Reserved for Future Issuance						300,000		300,000
Common Stock, Capital Shares Reserved for Future Issuance						1,400,000		1,100,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	59,075
Time-based Restricted Stock Units [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 100		$ 100
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				2 years
Time-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 138		$ 138
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance		120,372		120,372		147,372
Dividends Payable		$ 40		$ 40
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested		$ 366		$ 366
Performance-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance		320,000		320,000		200,000
Dividends Payable		$ 0		$ 0
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount		$ 1,500		$ 1,500
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				3 years

Note 11 - Share-based Compens_4

Note 11 - Share-based Compensation - Restricted Stock Units Activity (Details) - The 2014 Plan [Member]	9 Months Ended
	Sep. 28, 2019$ / sharesshares
Time-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares	147,372
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.46
Granted (in shares) | shares	20,000
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 3.73
Vested (in shares) | shares	(35,000)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.41
Forfeited or expired (in shares) | shares	(12,000)
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.84
Outstanding non-vested (in shares) | shares	120,372
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.22
Performance-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares	200,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 5.06
Granted (in shares) | shares	167,148
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.35
Vested (in shares) | shares	(47,148)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 3.69
Forfeited or expired (in shares) | shares
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares
Outstanding non-vested (in shares) | shares	320,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 4.82

Note 12 - Treasury Stock Tran_2

Note 12 - Treasury Stock Transactions (Details Textual) - shares shares in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Stock Repurchase Program, 2016 [Member]
Treasury Stock, Shares, Acquired	0	0

Note 14 - Segment Information -

Note 14 - Segment Information - Results of the Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018	Dec. 29, 2018
Revenues	$ 40,250	$ 42,559	$ 142,550	$ 145,081
Cost of services	29,635	31,571	106,615	108,803
Gross profit	10,615	10,988	35,935	36,278
Selling, general and administrative	9,498	9,412	30,165	29,909
Depreciation and amortization	386	344	1,191	1,156
Operating income (loss)	731	1,232	4,579	3,842
Total assets	91,740	73,428	91,740	73,428	$ 81,510
Capital expenditures	63	816	301	1,414
Severance, professional fees and other charges				1,371
Engineering [Member]
Revenues	15,140	19,424	52,778	62,412
Cost of services	10,984	14,049	38,666	45,706
Gross profit	4,156	5,375	14,112	16,706
Selling, general and administrative	2,996	3,780	10,486	12,006
Depreciation and amortization	293	236	879	785
Operating income (loss)	867	1,359	2,747	3,915
Total assets	53,639	40,643	53,639	40,643
Capital expenditures	(11)	465	76	856
Severance, professional fees and other charges
Specialty Health Care [Member]
Revenues	16,765	15,106	64,305	60,599
Cost of services	12,795	11,665	49,395	46,822
Gross profit	3,970	3,441	14,910	13,777
Selling, general and administrative	4,205	3,648	12,990	12,255
Depreciation and amortization	74	85	250	294
Operating income (loss)	(309)	(292)	1,670	1,228
Total assets	25,822	18,874	25,822	18,874
Capital expenditures	2	151	107	207
Severance, professional fees and other charges
Information Technology [Member]
Revenues	8,345	8,029	25,467	22,070
Cost of services	5,856	5,857	18,554	16,275
Gross profit	2,489	2,172	6,913	5,795
Selling, general and administrative	2,297	1,984	6,689	5,648
Depreciation and amortization	19	23	62	77
Operating income (loss)	173	165	162	70
Total assets	7,773	7,110	7,773	7,110
Capital expenditures	19	90	36	108
Severance, professional fees and other charges
Corporate Segment [Member]
Revenues
Cost of services
Gross profit
Selling, general and administrative
Depreciation and amortization
Operating income (loss)				(1,371)
Total assets	4,506	6,801	4,506	6,801
Capital expenditures	$ 53	$ 110	$ 82	243
Severance, professional fees and other charges				$ 1,371

Note 14 - Segment Information_2

Note 14 - Segment Information - Revenues by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Revenues	$ 40,250	$ 42,559	$ 142,550	$ 145,081
UNITED STATES
Revenues	34,810	34,729	124,356	118,364
CANADA
Revenues	3,682	6,308	12,770	21,942
PUERTO RICO
Revenues	1,215	1,113	3,627	3,142
SERBIA
Revenues	$ 543	$ 409	$ 1,797	$ 1,633

Note 14 - Segment Information_3

Note 14 - Segment Information - Total Assets by Geographic Area (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018	Sep. 29, 2018
Total assets	$ 91,740	$ 81,510	$ 73,428
UNITED STATES
Total assets	72,814	61,417
CANADA
Total assets	12,316	14,230
PUERTO RICO
Total assets	1,997	1,954
SERBIA
Total assets	$ 4,616	$ 3,909

Note 15 - Income Taxes (Details

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 28, 2019	Mar. 30, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Income Tax Expense (Benefit), Total	$ 70		$ 253	$ 255	$ 736
Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Amount		$ 600
Effective Income Tax Rate Reconciliation, Percent, Total				25.90%	25.80%
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Effective Income Tax Rate Reconciliation, Percent, Total				28.30%	28.10%
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Effective Income Tax Rate Reconciliation, Percent, Total				26.50%	26.50%
Foreign Tax Authority [Member] | Ministry of Finance, Republic of Serbia [Member]
Effective Income Tax Rate Reconciliation, Percent, Total				15.00%	15.20%

Note 16 - Contingencies (Detail

Note 16 - Contingencies (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Dec. 29, 2018
Loss Contingency, Damages Sought, Value	$ 10,300
Estimated Litigation Liability	0
Loss Contingency, Receivable, Ending Balance	12,200	$ 8,900
Loss Contingency, Estimate of Possible Loss	$ 10,300

Note 17 - Leases (Details Textu

Note 17 - Leases (Details Textual) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 30, 2018	Dec. 29, 2018
Operating Lease, Right-of-Use Asset	$ 6,290
Operating Lease, Liability, Total	$ 6,539
Accounting Standards Update 2016-02 [Member]
Operating Lease, Right-of-Use Asset		$ 3,900
Operating Lease, Liability, Total		$ 4,100

Note 17 - Leases - Lease Expens

Note 17 - Leases - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 28, 2019	Sep. 28, 2019
Operating lease cost	$ 654	$ 1,643
Finance lease cost, Amortization of ROU assets	72	218
Finance lease cost, Interest on lease liabilities	1	4
Total finance lease cost	$ 73	$ 222

Note 17 - Leases - Cash Flow In

Note 17 - Leases - Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 28, 2019	Sep. 28, 2019
Operating cash flows from operating leases	$ 665	$ 1,605
Operating cash flows from finance leases	1	4
Financing cash flows from finance leases	72	216
Operating leases	774	7,756
Finance leases

Note 17 - Leases - Balance Shee

Note 17 - Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Operating lease right of use assets	$ 6,290
Other current liabilities	(2,275)
Operating lease liabilities	(4,264)
Total operating lease liabilities	(6,539)
Property and equipment - (ROU assets)	867
Accumulated depreciation	(387)
Property and equipment, net	480
Other current liabilities	(287)
Other long term liabilities	(194)
Total finance lease liabilities	$ (481)
Operating leases (years) (Year)	2 years 87 days
Finance leases (years) (Year)	1 year 255 days
Operating leases	4.09%
Finance leases	1.23%

Note 17 - Leases - Maturities o

Note 17 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 28, 2019USD ($)
2019, operating leases	$ 673
2019, finance leases	73
2020, operating leases	2,289
2020, finance leases	284
2021, operating leases	1,715
2021, finance leases	130
2022, operating leases	1,266
2022, finance leases
2023, operating leases	877
2023, finance leases
Thereafter, operating leases	186
Thereafter, finance leases
Total lease payments, operating leases	7,006
Total lease payments, finance leases	487
Less: imputed interest, operating leases	(467)
Less: imputed interest, finance leases	(6)
Total, operating leases	6,539
Total, finance leases	$ 481

Note 18 - Severance, Professi_2

Note 18 - Severance, Professional Fees, and Other Charges (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Severance, Professional Fees and Other Charges				$ 1,371
Former Chief Executive Officer [Member] | Severance Accrued and Related Payroll Taxes, Continuation of Certain Benefits and Professional Fees [Member]
Severance, Professional Fees and Other Charges				900
Former Chief Executive Officer [Member] | Severance, Legal Fees Related to Acquisition, and Other Legal Miscellaneous Charges [Member]
Severance, Professional Fees and Other Charges				$ 500